Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration

Inclusion Criteria: * Subjects must have a normal creatinine clearance of ≥60 mL/min * Subjects who self-identify their race as Asian Exclusion Criteria: * History of any clinically significant medical, neurologic or psychiatric disease as judged by the investigator * History of symptomatic orthostatic hypotension (ie, postural syncope) * Subjects who have received any radiolabelled study drug within 12 months of the Screening Visit. * Subjects who are monitored for radioactivity as part of their occupation * Subjects who have been exposed to radiation levels above background, (eg, throughX-Ray examinations) of \>5mSv in the last year, \>10 mSv over the last 5 years or a cumulative total of \>1mSv per year of life.